Research from the 2024 ASCO Gastrointestinal Cancers Symposium will highlight studies that explore treatment options for people with cancers of the gastrointestinal tract, such as colorectal cancer, esophageal cancer, liver cancer, and neuroendocrine tumors.
Alexandra Vitale shares what it has been like living with von Hippel-Lindau disease since age 5, how she coped with receiving multiple cancer diagnoses, and how joining a clinical trial and trying a new treatment helped her find hope.
Cancer survivor Bethany Hart describes the emotions and decisions that followed her cancer diagnosis, including how she managed making important choices about her care and her advice for people with cancer trying to do the same.
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor.
When Josh Mailman was diagnosed with a pancreatic neuroendocrine tumor, he didn’t expect his life to be defined by two of Dr. Seuss’ books—Did I Ever Tell You How Lucky You Are? and Oh, The Places You’ll Go. Now as a patient advocate, his goal is to ensure that others diagnosed with rare cancers do not need to rely on luck and travel to get the best outcome.
